, volume 14 , issue 2 , pages 153-168

Novel antiviral drug discovery strategies to tackle drug-resistant mutants of influenza virus strains

Woo Jin Shin ¹

Baik L. Seong ^{2, 3}

Hide authors affiliations Show authors affiliations: 3 affiliations

Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA |

Department of Biotechnology, College of Life Science and Biotechnology, Yonsei University, Seoul, South Korea |

Vaccine Translational Research Center, Yonsei University, Seoul, South Korea |

Publication type: Journal Article

Publication date: 2018-12-26

Taylor & Francis

Expert Opinion on Drug Discovery

scimago Q1

wos Q1

SJR: 1.195

CiteScore: 10.6

Impact factor: 4.9

ISSN: 17460441, 1746045X

DOI: 10.1080/17460441.2019.1560261

Copy DOI

PubMed ID: 30585088

Drug Discovery

Found

1 citation

Osolodkin Dmitry

🥼 🤝

PhD in Chemistry

80 publications, 1 731 citations

h-index: 23

Sechenov First Moscow State Medical University

M.P. Chumakov Federal Scientific Center for Research and Development of Immunobiological Drugs of the Russian Academy of Sciences

1 citation

Prokopyeva Elena

🥼 🤝

24 publications, 195 citations, 1 review

h-index: 9

Federal Research Center of Fundamental and Translational Medicine

Research interests

Viruses

Top-30

Journals

	1 2
Viruses	Viruses, 2, 4.55% Viruses 2 publications, 4.55%
Chemical Society Reviews	Chemical Society Reviews, 2, 4.55% Chemical Society Reviews 2 publications, 4.55%
European Journal of Medicinal Chemistry	European Journal of Medicinal Chemistry, 2, 4.55% European Journal of Medicinal Chemistry 2 publications, 4.55%
Frontiers in Cellular and Infection Microbiology	Frontiers in Cellular and Infection Microbiology, 2, 4.55% Frontiers in Cellular and Infection Microbiology 2 publications, 4.55%
Future Virology	Future Virology, 1, 2.27% Future Virology 1 publication, 2.27%
Journal of Biomedical Science	Journal of Biomedical Science, 1, 2.27% Journal of Biomedical Science 1 publication, 2.27%
International Journal of Immunopathology and Pharmacology	International Journal of Immunopathology and Pharmacology, 1, 2.27% International Journal of Immunopathology and Pharmacology 1 publication, 2.27%
Frontiers in Immunology	Frontiers in Immunology, 1, 2.27% Frontiers in Immunology 1 publication, 2.27%
Frontiers in Bioengineering and Biotechnology	Frontiers in Bioengineering and Biotechnology, 1, 2.27% Frontiers in Bioengineering and Biotechnology 1 publication, 2.27%
Frontiers in Microbiology	Frontiers in Microbiology, 1, 2.27% Frontiers in Microbiology 1 publication, 2.27%
Cellular and Molecular Life Sciences	Cellular and Molecular Life Sciences, 1, 2.27% Cellular and Molecular Life Sciences 1 publication, 2.27%
Acta Pharmaceutica Sinica B	Acta Pharmaceutica Sinica B, 1, 2.27% Acta Pharmaceutica Sinica B 1 publication, 2.27%
Molecular Therapy - Nucleic Acids	Molecular Therapy - Nucleic Acids, 1, 2.27% Molecular Therapy - Nucleic Acids 1 publication, 2.27%
Biomedicine and Pharmacotherapy	Biomedicine and Pharmacotherapy, 1, 2.27% Biomedicine and Pharmacotherapy 1 publication, 2.27%
Drug Discovery Today	Drug Discovery Today, 1, 2.27% Drug Discovery Today 1 publication, 2.27%
Bioorganic and Medicinal Chemistry	Bioorganic and Medicinal Chemistry, 1, 2.27% Bioorganic and Medicinal Chemistry 1 publication, 2.27%
Transboundary and Emerging Diseases	Transboundary and Emerging Diseases, 1, 2.27% Transboundary and Emerging Diseases 1 publication, 2.27%
Peptides	Peptides, 1, 2.27% Peptides 1 publication, 2.27%
Clinical and Translational Science	Clinical and Translational Science, 1, 2.27% Clinical and Translational Science 1 publication, 2.27%
Journal of Biomolecular Structure and Dynamics	Journal of Biomolecular Structure and Dynamics, 1, 2.27% Journal of Biomolecular Structure and Dynamics 1 publication, 2.27%
Antiviral Therapy	Antiviral Therapy, 1, 2.27% Antiviral Therapy 1 publication, 2.27%
mBio	mBio, 1, 2.27% mBio 1 publication, 2.27%
Pharmacognosy Magazine	Pharmacognosy Magazine, 1, 2.27% Pharmacognosy Magazine 1 publication, 2.27%
Expert Opinion on Drug Discovery	Expert Opinion on Drug Discovery, 1, 2.27% Expert Opinion on Drug Discovery 1 publication, 2.27%
Algal Research	Algal Research, 1, 2.27% Algal Research 1 publication, 2.27%
Microbiology spectrum	Microbiology spectrum, 1, 2.27% Microbiology spectrum 1 publication, 2.27%
Russian Chemical Bulletin	Russian Chemical Bulletin, 1, 2.27% Russian Chemical Bulletin 1 publication, 2.27%
Meditsinskiy sovet = Medical Council	Meditsinskiy sovet = Medical Council, 1, 2.27% Meditsinskiy sovet = Medical Council 1 publication, 2.27%
Signal Transduction and Targeted Therapy	Signal Transduction and Targeted Therapy, 1, 2.27% Signal Transduction and Targeted Therapy 1 publication, 2.27%
	1 2

Publishers

	2 4 6 8 10 12 14
Elsevier	Elsevier, 13, 29.55% Elsevier 13 publications, 29.55%
Springer Nature	Springer Nature, 6, 13.64% Springer Nature 6 publications, 13.64%
Frontiers Media S.A.	Frontiers Media S.A., 5, 11.36% Frontiers Media S.A. 5 publications, 11.36%
Taylor & Francis	Taylor & Francis, 3, 6.82% Taylor & Francis 3 publications, 6.82%
SAGE	SAGE, 2, 4.55% SAGE 2 publications, 4.55%
MDPI	MDPI, 2, 4.55% MDPI 2 publications, 4.55%
Wiley	Wiley, 2, 4.55% Wiley 2 publications, 4.55%
Royal Society of Chemistry (RSC)	Royal Society of Chemistry (RSC), 2, 4.55% Royal Society of Chemistry (RSC) 2 publications, 4.55%
American Society for Microbiology	American Society for Microbiology, 2, 4.55% American Society for Microbiology 2 publications, 4.55%
Medknow	Medknow, 1, 2.27% Medknow 1 publication, 2.27%
Cold Spring Harbor Laboratory	Cold Spring Harbor Laboratory, 1, 2.27% Cold Spring Harbor Laboratory 1 publication, 2.27%
Remedium, Ltd.	Remedium, Ltd., 1, 2.27% Remedium, Ltd. 1 publication, 2.27%
OOO Zhurnal "Mendeleevskie Soobshcheniya"	OOO Zhurnal "Mendeleevskie Soobshcheniya", 1, 2.27% OOO Zhurnal "Mendeleevskie Soobshcheniya" 1 publication, 2.27%
IGI Global	IGI Global, 1, 2.27% IGI Global 1 publication, 2.27%
International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA)	International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA), 1, 2.27% International Research and Cooperation Association for Bio & Socio-Sciences Advancement (IRCA-BSSA) 1 publication, 2.27%
	2 4 6 8 10 12 14

We do not take into account publications without a DOI.
Statistics recalculated weekly.

Are you a researcher?

Create a profile to get free access to personal recommendations for colleagues and new articles.

Metrics

Cite this

GOST |

Cite this

GOST Copy

Shin W. J., Seong B. L. Novel antiviral drug discovery strategies to tackle drug-resistant mutants of influenza virus strains // Expert Opinion on Drug Discovery. 2018. Vol. 14. No. 2. pp. 153-168.

GOST all authors (up to 50) Copy

Shin W. J., Seong B. L. Novel antiviral drug discovery strategies to tackle drug-resistant mutants of influenza virus strains // Expert Opinion on Drug Discovery. 2018. Vol. 14. No. 2. pp. 153-168.

RIS |

Cite this

RIS Copy

TY - JOUR

DO - 10.1080/17460441.2019.1560261

UR - https://doi.org/10.1080/17460441.2019.1560261

TI - Novel antiviral drug discovery strategies to tackle drug-resistant mutants of influenza virus strains

T2 - Expert Opinion on Drug Discovery

AU - Shin, Woo Jin

AU - Seong, Baik L.

PY - 2018

DA - 2018/12/26

PB - Taylor & Francis

SP - 153-168

IS - 2

VL - 14

PMID - 30585088

SN - 1746-0441

SN - 1746-045X

ER -

BibTex |

Cite this

BibTex (up to 50 authors) Copy

@article{2018_Shin,

author = {Woo Jin Shin and Baik L. Seong},

title = {Novel antiviral drug discovery strategies to tackle drug-resistant mutants of influenza virus strains},

journal = {Expert Opinion on Drug Discovery},

year = {2018},

volume = {14},

publisher = {Taylor & Francis},

month = {dec},

url = {https://doi.org/10.1080/17460441.2019.1560261},

number = {2},

pages = {153--168},

doi = {10.1080/17460441.2019.1560261}

}

MLA

Cite this

MLA Copy

Shin, Woo Jin, et al. “Novel antiviral drug discovery strategies to tackle drug-resistant mutants of influenza virus strains.” Expert Opinion on Drug Discovery, vol. 14, no. 2, Dec. 2018, pp. 153-168. https://doi.org/10.1080/17460441.2019.1560261.

Publisher

Taylor & Francis

Journal

Expert Opinion on Drug Discovery

scimago Q1

wos Q1

SJR

1.195

CiteScore

10.6

Impact factor

4.9

ISSN

17460441 (Print)

1746045X (Electronic)